In patients with severe COVID-19 who experienced a poor prognosis or even died, these authors reported an increased expression of inflammatory and antiviral pathways, in which the IL10 family of cytokines is a key determinant (Shivram et al., 2023). This evidence concerns the gene IL10 and COVID-19.